Gotham Asset Management »

Halozyme Therapeutics shares owned by Gotham Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Gotham Asset Management from 13F filings

Historical chart of Gotham Asset Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Gotham Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Gotham Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.6M 98k 36.96
2023-09-30 $1.6M 42k 38.20
2023-06-30 $1.3M 36k 36.07
2023-03-31 $1.7M 44k 38.19
2022-12-31 $1.6M 27k 56.90
2022-09-30 $1.2M 30k 39.54
2022-06-30 $1.3M 31k 44.01
2022-03-31 $1.6M 39k 39.87
2021-12-31 $1.8M 45k 40.21
2021-09-30 $953k 23k 40.67
2021-06-30 $1.6M 34k 45.41
2021-03-31 $1.9M 46k 41.68
2020-12-31 $907k 21k 42.70
2020-09-30 $549k 21k 26.28
2020-06-30 $560k 21k 26.82
2020-03-31 $319k 18k 17.99
2019-09-30 $207k 13k 15.52
2019-06-30 $223k 13k 17.19
2018-06-30 $1.0M 62k 16.86
2018-03-31 $2.3M 116k 19.59
2016-06-30 $296k 34k 8.63
2015-09-30 $389k 29k 13.43
2015-06-30 $829k 37k 22.59